ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Oct 17, 2022 12:00 JST
Source:
Novotech Health Holdings Pte Ltd
The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval
SYDNEY, AU, Oct 17, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar for biotechs considering the clinical research opportunities in Asia Pacific and the regulatory pathways to achieving FDA approval.
Novotech has operations across Asia Pacific and the US offering a unique and unparalleled suite of CRO services for early to late phase biotech clinical research.
The webinar features regulatory affairs and investment leaders from North America and Asia Pacific who will discuss:
- why biotech companies are increasingly exploring clinical opportunities in Asia Pacific to generate diverse, globally accepted clinical trial data
- what actionable strategies can be implemented to leverage Asia Pacific's recruitment potential to accelerate your clinical development
- how Phase 1 data from Australia is acceptable to the FDA and can be used to launch global drug development programs
- deep insight into processes for designing and delivering a robust clinical program
- biotech challenges and opportunities in the post-COVID environment with a focus on global investments and drug pipelines
Register for the webinar here
https://webinars.endpts.com/the-biotech-landscape-market-trends-priorities-predictions-and-pathways-to-fda-approval/
October 18, 2022
1:00 pm - 2:00 pm EDT
The industry leaders presenting include:
- Yi Larson, Chief Financial Officer of LianBio. Formerly Executive Vice President and Chief Financial Officer at Turning Point Therapeutics, Inc., and Goldman Sachs & Co. LLC, Managing Director of Healthcare Investment Banking
- Kasey Kime, Director of Regulatory Affairs for Novotech's in-house consulting group, BioDesk
- Dr. Jeanne M. Novak, President and CEO of CBR International Corp., a full-service product, clinical, and regulatory strategy group
- Dr. Fred Cohen, a Co-Founder and Chairman of Monograph Capital Partners. He is also a Co-Founder and Senior Managing Director at Vida Ventures.
Novotech has decades of biotech drug development experience, exceptional site and investigator relationships, access to vast patient populations, and a project management approach focused on problem-solving, ownership and flexibility. Consistent investment in advanced training and technology systems combine to deliver a specialist full-service biotech CRO solution.
Novotech has recently been benchmarked as a top 10 CRO among the world's leading CROs, is a finalist in the prestigious Scrip awards, and has just been awarded the Gene & Cell Therapy Excellence Award. In Asia Pacific Novotech has more than 50 Leading Site Partnership agreements with major medical research institutions which delivers exclusive benefits for sponsors.
About Novotech
Novotech is the leading Asia-Pacific biotech specialist CRO. Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases. It has been instrumental in the success of approximately 4,000 clinical trials across a broad range of therapeutic areas. Novotech is well-positioned to serve biopharma clients conducting clinical trials in Asia-Pacific and the US. For more information visit
https://novotech-cro.com/contact
Media Contact
David James
E:
communications@novotech-cro.com
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427
Source: Novotech Health Holdings Pte Ltd
Sectors: BioTech, Healthcare & Pharm, Clinical Trials
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Mitsubishi Power Secures Major Gas Turbine and Services Order for Al Wahda Open Cycle Gas Turbine Power Plant in Morocco
Feb 12, 2025 16:21 JST
MHI Delivers Final 7000-Series AGT Trainset for the Astram Line
Feb 12, 2025 12:24 JST
Fujitsu and Yokohama National University achieve world's first real-time prediction of tornadoes associated with typhoons using supercomputer Fugaku
Feb 12, 2025 11:37 JST
NEC Solution Modernizes Network Infrastructure Construction Work
Feb 10, 2025 15:05 JST
Olympus Recognized on CDP's "A List", the Highest Rating in the Field of Climate Change
Feb 10, 2025 11:00 JST
uSMART Capital, LLC officially approved for U.S. FINRA license
Feb 07, 2025 17:40 JST
TANAKA to Provide Medals for the Tokyo Marathon 2025 That Represent All the Participants in the Event with Woven Lines
Feb 07, 2025 04:00 JST
MHI Thermal Systems to Launch New Model of the "Ene-Conductor" Heat Source Control System
Feb 06, 2025 16:51 JST
Hitachi establishes its fourth Corporate Venture Capital Fund to capture technology turning points and future growth opportunities
Feb 06, 2025 16:32 JST
Approval in Principle (AiP) Acquired from Classification Society for Low-Pressure Type Coastal Liquefied CO2 Carrier
Feb 05, 2025 17:46 JST
Toyota Powers On New North Carolina Automotive Battery Plant
Feb 05, 2025 13:59 JST
Toyota to Form Comprehensive Partnership on Carbon Neutrality with Shanghai and Establish a Company to Develop and Produce BEVs and Batteries
Feb 05, 2025 13:56 JST
Fujitsu to highlight AI-powered network technologies at MWC Barcelona 2025
Feb 05, 2025 10:25 JST
TOYOTA GAZOO Racing Launches Evolved GR Corolla in Japan
Feb 04, 2025 18:41 JST
Mitsubishi Heavy Industries Achieves Double-Digit Order Intake and Profit Growth in First Three Quarters, Raises Full-Year Guidance
Feb 04, 2025 18:34 JST
MAZDA TRANS AOYAMA Opens in Minami-Aoyama
Feb 04, 2025 17:38 JST
Fujitsu launches gen AI software analysis and visualization service to support optimal modernization planning
Feb 04, 2025 11:39 JST
Eisai to Provide Guidance on Reducing the Risk of Cognitive Decline and Nutrition, and Development Guidelines for Home Delivery Meals/Meal Kits to Food-Related Companies
Feb 03, 2025 17:23 JST
MHI Group Presents "Best Innovation 2024" Awards for Products and Activities that Contribute to Solving Social Issues
Feb 03, 2025 14:31 JST
Fujitsu and Tokai National Higher Education and Research System leverage explainable AI to enhance space weather prediction in collaboration with JAXA
Feb 03, 2025 12:05 JST
More Latest Release >>
Related Release
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
February 15 2023 09:00 JST
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific
February 10 2023 19:00 JST
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW
February 03 2023 13:00 JST
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
January 12 2023 15:00 JST
Novotech Acquires European CRO, Strengthens Global Operations
January 12 2023 15:00 JST
Novotech is Gold Sponsor at Biotech Showcase 2023
December 20 2022 11:00 JST
Data Shows 50% of New Trials Have Sites in Asia Pacific
December 15 2022 10:00 JST
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials
December 06 2022 11:00 JST
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy
November 11 2022 17:00 JST
Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper
October 25 2022 18:00 JST
More Press release >>